XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:      
Net increase (decrease) in net assets resulting from operations $ 4,155,515 $ 18,619,122 $ 26,918,340
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Proceeds from sale and settlements of investments 100,348,370 112,313,260 66,642,920
Purchases, originations and participations (173,921,300) (99,173,887) (76,652,712)
Investment increases due to payment-in-kind interest (1,355,918) (1,207,710) (1,525,392)
Net amortization of premium (discount) on investments (622,798) (388,667) (1,560,684)
Amortization of debt issuance cost 369,422 347,908 370,329
Amortization of deferred financing cost 559,419 565,619 286,597
Net realized (gains) losses from investments 11,922,506 (7,292,299) 11,533,039
Net unrealized (gains) losses on investments (10,727,490) (5,705,864) (31,941,213)
(Increase) decrease in operating assets:      
Interest receivable 110,194 (342,483) (243,539)
Paydown receivable 112,500
Other receivable 20,867 (34,413) 5,567
Dividends receivable (19,482) 138,011 107,851
Due from affiliate (481,831) 318,714 (137,252)
Other assets (1,680,452) (233,323) 359,677
Prepaid share repurchase 4,773 97,904 290,137
Receivable for investments sold 2,934,226 984,400 (3,940,175)
Provision for deferred taxes on unrealized appreciation/(depreciation) on investments (347,748) (887,099)
Taxes payable 137,538
Increase (decrease) in operating liabilities:      
Accounts payable and accrued expenses (1,343,261) 2,503,166 1,026,707
Interest and fees payable 419,531 77,645 187,273
Other liabilities 2,145,342 (138,635) (140,251)
Deferred revenue (421,685) 96,083
Due to Affiliate 44,217 88,148
Payable for investments purchased (4,123,059) (12,426,941)
Administrator expenses payable (74,911)
Net cash provided by (used in) operating activities (67,328,360) 16,104,773 (20,706,050)
Cash Flows from Financing Activities:      
Debt issuance 55,418,666 76,471,498 36,441,941
Paydowns on debt (43,500,000) (25,178,988) (30,521,800)
Debt issuance costs paid (169,888)
Deferred financing costs (1,183,506) (627,175) (935,721)
Distributions paid to shareholders (2,888,283) (2,645,925)
Repurchase of common shares (800,705) (2,370,959) (1,058,213)
Net cash provided by (used in) financing activities 7,046,172 45,478,563 3,926,207
Net increase (decrease) in cash and cash equivalents (60,282,188) 61,583,336 (16,779,843)
Cash and cash equivalents, beginning of period 67,571,559 5,988,223 22,768,066
Cash and cash equivalents, end of period 7,289,371 67,571,559 5,988,223
Supplemental information:      
Interest paid during the period 8,762,139 5,532,959 4,647,166
Non-cash purchase of investments 12,665,596 45,900,000
Non-cash sale of investments $ 12,665,596 $ 45,900,000